Lipid-associated macrophages between aggravation and alleviation of metabolic diseases
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Lipid-associated macrophages (LAMs) are phagocytic cells with lipid-handling capacity identified in various metabolic derangements. During disease development, they locate to atherosclerotic plaques, adipose tissue (AT) of individuals with obesity, liver lesions in steatosis and steatohepatitis, and the intestinal lamina propria. LAMs can also emerge in the metabolically demanding microenvironment of certain tumors. In this review, we discuss major questions regarding LAM recruitment, differentiation, and self-renewal, and, ultimately, their acute and chronic functional impact on the development of metabolic diseases. Further studies need to clarify whether and under which circumstances LAMs drive disease progression or resolution and how their phenotype can be modulated to ameliorate metabolic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors
Gomez Perdiguero, E., Klapproth, K., Schulz, C., Busch, K., Azzoni, E., Crozet, L., Garner, H., Trouillet, C., de Bruijn, M. F., Geissmann, F., et al. (2015) · Nature · doi:10.1038/nature13989 · Cited by 2,339
Diversity, Mechanisms, and Significance of Macrophage Plasticity
Locati, M., Curtale, G., & Mantovani, A. (2020) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012718 · Cited by 2,199
Macrophages as tools and targets in cancer therapy
Mantovani, A., Allavena, P., Marchesi, F., & Garlanda, C. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00520-5 · Cited by 1,807
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784
Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner
Jaitin, D. A., Adlung, L., Thaiss, C. A., Weiner, A., Li, B., Descamps, H., Lundgren, P., Bleriot, C., Liu, Z., Deczkowska, A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.054 · Cited by 1,377
Research works printed but not linked: 65
- O’Neill, 2016, A guide to immunometabolism for immunologists, Nat. Rev. Immunol., 16, 553, 10.1038/nri.2016.70 · DOI · Paper page
- Schleh, 2023, Metaflammation in obesity and its therapeutic targeting, Sci. Transl. Med., 15, 723, 10.1126/scitranslmed.adf9382 · DOI · Paper page
- Rodríguez-Morales, 2023, Macrophage phenotypes and functions: resolving inflammation and restoring homeostasis, Trends Immunol., 44, 986, 10.1016/j.it.2023.10.004 · DOI · Paper page
- Wang, 2023, An immune cell atlas reveals the dynamics of human macrophage specification during prenatal development, Cell, 186, 4454, 10.1016/j.cell.2023.08.019 · DOI · Paper page
- Norreen-Thorsen, 2022, A human adipose tissue cell-type transcriptome atlas, Cell Rep., 40, 10.1016/j.celrep.2022.111046 · DOI
- Nance, 2022, Adipose tissue macrophages: regulators of adipose tissue immunometabolism during obesity, Mol. Metab., 66, 10.1016/j.molmet.2022.101642 · DOI
- Stansbury, 2023, A lipid-associated macrophage lineage rewires the spatial landscape of adipose tissue in early obesity, JCI Insight, 8, 10.1172/jci.insight.171701 · DOI
- Sárvári, 2021, Plasticity of epididymal adipose tissue in response to diet-induced obesity at single-nucleus resolution, Cell Metab., 33, 437, 10.1016/j.cmet.2020.12.004 · DOI · Paper page
- Zamarron, 2017, Macrophage proliferation sustains adipose tissue inflammation in formerly obese mice, Diabetes, 66, 392, 10.2337/db16-0500 · DOI · Paper page
- Amano, 2014, Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation, Cell Metab., 19, 162, 10.1016/j.cmet.2013.11.017 · DOI · Paper page
- Deczkowska, 2020, The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway, Cell, 181, 1207, 10.1016/j.cell.2020.05.003 · DOI · Paper page
- Sakuma, 2023, Lysophosphatidic acid triggers inflammation in the liver and white adipose tissue in rat models of 1-acyl-sn-glycerol-3-phosphate acyltransferase 2 deficiency and overnutrition, Proc. Natl. Acad. Sci. USA, 120, 10.1073/pnas.2312666120 · DOI
- Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, J. Clin. Invest., 112, 1796, 10.1172/JCI200319246 · DOI · Paper page
- Xu, 2003, Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance, J. Clin. Invest., 112, 1821, 10.1172/JCI200319451 · DOI · Paper page
- Kratz, 2014, Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages, Cell Metab., 20, 614, 10.1016/j.cmet.2014.08.010 · DOI · Paper page
- Hill, 2018, Distinct macrophage populations direct inflammatory versus physiological changes in adipose tissue, Proc. Natl. Acad. Sci U. S. A., 115, E5096, 10.1073/pnas.1802611115 · DOI · Paper page
- Kane, 2019, Innate immune control of adipose tissue homeostasis, Trends Immunol., 40, 857, 10.1016/j.it.2019.07.006 · DOI · Paper page
- Jacks, 2024, Macrophage and T cell networks in adipose tissue, Nat. Rev. Endocrinol., 20, 50, 10.1038/s41574-023-00908-2 · DOI
- Maniyadath, 2023, Adipose tissue at single-cell resolution, Cell Metab., 35, 386, 10.1016/j.cmet.2023.02.002 · DOI · Paper page
- Vijay, 2019, Single-cell analysis of human adipose tissue identifies depot- and disease-specific cell types, Nat. Metab., 2, 97, 10.1038/s42255-019-0152-6 · DOI · Paper page
- Flaherty, 2019, A lipase-independent pathway of lipid release and immune modulation by adipocytes, Science, 363, 989, 10.1126/science.aaw2586 · DOI · Paper page
- Park, 2015, Triggering receptor expressed on myeloid cells 2 (TREM2) promotes adipogenesis and diet-induced obesity, Diabetes, 64, 117, 10.2337/db13-1869 · DOI · Paper page
- Tanaka, 2018, A potential novel pathological implication of serum soluble triggering receptor expressed on myeloid cell 2 in insulin resistance in a general Japanese population: the Hisayama study, Diabetes Res. Clin. Pract., 146, 225, 10.1016/j.diabres.2018.10.007 · DOI
- Reinisch, 2024, Adipocyte p53 coordinates the response to intermittent fasting by regulating adipose tissue immune cell landscape, Nat. Commun., 15, 1391, 10.1038/s41467-024-45724-y · DOI
- Barreby, 2022, Macrophage functional diversity in NAFLD - more than inflammation, Nat. Rev. Endocrinol., 18, 461, 10.1038/s41574-022-00675-6 · DOI · Paper page
- Seidman, 2020, Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis, Immunity, 52, 1057, 10.1016/j.immuni.2020.04.001 · DOI · Paper page
- Li, 2023, LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis, Nat. Commun., 14, 4436, 10.1038/s41467-023-40183-3 · DOI
- Kanda, 2018, Apoptosis and non-alcoholic fatty liver diseases, World J. Gastroenterol., 24, 2661, 10.3748/wjg.v24.i25.2661 · DOI · Paper page
- Medina, 2016, Do not let death do us part: ‘find-me’ signals in communication between dying cells and the phagocytes, Cell Death Differ., 23, 979, 10.1038/cdd.2016.13 · DOI · Paper page
- Indira Chandran, 2023, Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness, Hepatology, 77, 558, 10.1002/hep.32620 · DOI · Paper page
- Petrescu, 2022, Chronic inflammation—a link between nonalcoholic fatty liver disease (NAFLD) and dysfunctional adipose tissue, Medicina (B Aires), 58, 641, 10.3390/medicina58050641 · DOI
- Guha Ray, 2023, The diverse roles of macrophages in metabolic inflammation and its resolution, Front. Cell Dev. Biol., 11, 10.3389/fcell.2023.1147434 · DOI
- Zhou, 2024, Hepatic danger signaling triggers TREM2 + macrophage induction and drives steatohepatitis via MS4A7-dependent inflammasome activation, Sci. Transl. Med., 16, 1866, 10.1126/scitranslmed.adk1866 · DOI · Paper page
- Krenkel, 2018, Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis, Hepatology, 67, 1270, 10.1002/hep.29544 · DOI · Paper page
- Lin, 2019, Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression, JCI Insight, 4, 10.1172/jci.insight.124574 · DOI · Paper page
- Zernecke, 2020, Meta-analysis of leukocyte diversity in atherosclerotic mouse aortas, Circ. Res., 127, 402, 10.1161/CIRCRESAHA.120.316903 · DOI · Paper page
- Zernecke, 2023, Integrated single-cell analysis-based classification of vascular mononuclear phagocytes in mouse and human atherosclerosis, Cardiovasc. Res., 119, 1676, 10.1093/cvr/cvac161 · DOI · Paper page
- McArdle, 2019, Migratory and dancing macrophage subsets in atherosclerotic lesions, Circ. Res., 125, 1038, 10.1161/CIRCRESAHA.119.315175 · DOI
- Piollet, 2024, TREM2 protects from atherosclerosis by limiting necrotic core formation, Nat. Cardiovasc. Res., 3, 269, 10.1038/s44161-024-00429-9 · DOI
- Endo-Umeda, 2022, Myeloid LXR (liver X receptor) deficiency induces inflammatory gene expression in foamy macrophages and accelerates atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 42, 719, 10.1161/ATVBAHA.122.317583 · DOI
- Patterson, 2023, Trem2 promotes foamy macrophage lipid uptake and survival in atherosclerosis, Nat. Cardiovasc. Res., 2, 1015, 10.1038/s44161-023-00354-3 · DOI · Paper page
- Guo, 2023, TREM2 promotes cholesterol uptake and foam cell formation in atherosclerosis, Cell. Mol. Life Sci., 80, 137, 10.1007/s00018-023-04786-9 · DOI
- Dib, 2023, Lipid-associated macrophages transition to an inflammatory state in human atherosclerosis, increasing the risk of cerebrovascular complications, Nat. Cardiovasc. Res., 2, 656, 10.1038/s44161-023-00295-x · DOI
- Moreira Lopes, 2020, Macrophage polarization in intestinal inflammation and gut homeostasis, Inflamm. Res., 69, 1163, 10.1007/s00011-020-01398-y · DOI
- Castoldi, 2023, Metabolic and functional remodeling of colonic macrophages in response to high-fat diet-induced obesity, iScience, 26, 10.1016/j.isci.2023.107719 · DOI
- Du, 2001, Lysosomal acid lipase-deficient mice: depletion of white and brown fat, severe hepatosplenomegaly, and shortened life span, J. Lipid Res., 42, 489, 10.1016/S0022-2275(20)31157-3 · DOI · Paper page
- Bianco, 2024, Regional differences in the small intestinal proteome of control mice and of mice lacking lysosomal acid lipase, J. Proteome Res., 23, 1506, 10.1021/acs.jproteome.4c00082 · DOI
- Bianco, 2023, Impact of (intestinal) LAL deficiency on lipid metabolism and macrophage infiltration, Mol. Metab., 73, 10.1016/j.molmet.2023.101737 · DOI
- Bishop, 2023, Age-dependent microglial disease phenotype results in functional decline in gut macrophages, Gastro Hep Adv., 2, 261, 10.1016/j.gastha.2022.09.006 · DOI
- Li, 2023, Regulation of systemic metabolism by tissue-resident immune cell circuits, Immunity, 56, 1168, 10.1016/j.immuni.2023.05.001 · DOI
- Thomas, 2021, The ontogeny and function of placental macrophages, Front. Immunol., 12, 10.3389/fimmu.2021.771054 · DOI
- Dvir-Szternfeld, 2022, Alzheimer’s disease modification mediated by bone marrow-derived macrophages via a TREM2-independent pathway in mouse model of amyloidosis, Nat. Aging, 2, 60, 10.1038/s43587-021-00149-w · DOI · Paper page
- Kirschenbaum, 2024, Time-resolved single-cell transcriptomics defines immune trajectories in glioblastoma, Cell, 187, 149, 10.1016/j.cell.2023.11.032 · DOI · Paper page
- Kerzel, 2023, In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases, Cancer Cell, 41, 1892, 10.1016/j.ccell.2023.09.014 · DOI
- Nasir, 2023, Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies, Trends Immunol., 44, 971, 10.1016/j.it.2023.10.007 · DOI · Paper page
- Muir, 2018, Frontline science: rapid adipose tissue expansion triggers unique proliferation and lipid accumulation profiles in adipose tissue macrophages, J. Leukoc. Biol., 103, 615, 10.1002/JLB.3HI1017-422R · DOI
- Bianco, 2023, Glycoprotein non-metastatic protein B (GPNMB): the missing link between lysosomes and obesity, Exp. Clin. Endocrinol. Diabetes, 131, 639, 10.1055/a-2192-0101 · DOI
- Liu, 2022, Lipid-associated macrophages in the tumor-adipose microenvironment facilitate breast cancer progression, Oncoimmunology, 11, 10.1080/2162402X.2022.2085432 · DOI · Paper page
- Huang, 2023, TMEM147 aggravates the progression of HCC by modulating cholesterol homeostasis, suppressing ferroptosis, and promoting the M2 polarization of tumor-associated macrophages, J. Exp. Clin. Cancer Res., 42, 286, 10.1186/s13046-023-02865-0 · DOI
- Masetti, 2022, Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer, J. Exp. Med., 219, 10.1084/jem.20210564 · DOI · Paper page
- Vogel, 2022, Lipid scavenging macrophages and inflammation, Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 1867
- Su, 2020, Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages, Cancer Res., 80, 1438, 10.1158/0008-5472.CAN-19-2994 · DOI · Paper page
- Timperi, 2022, Lipid-associated macrophages are induced by cancer-associated fibroblasts and mediate immune suppression in breast cancer, Cancer Res., 82, 3291, 10.1158/0008-5472.CAN-22-1427 · DOI · Paper page
- Yang, 2022, CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis, Nat. Commun., 13, 5782, 10.1038/s41467-022-33349-y · DOI · Paper page
- Wu, 2019, Lipid droplet-dependent fatty acid metabolism controls the immune suppressive phenotype of tumor-associated macrophages, EMBO Mol. Med., 11, 10.15252/emmm.201910698 · DOI · Paper page
Cited by
Sakuma, I., Gaspar, R. C., Nasiri, A. R., Dufour, S., Kahn, M., Zheng, J., LaMoia, T. E., Guerra, M. T., Taki, Y., Kawashima, Y., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2502978122 · Cited by 46
Martin, O. P., Wallace, M. S., Oetheimer, C., Patel, H. B., Butler, E. C., Wong, L. P., Huang, P., Elbaz, J., Costentin, C., Salloum, S., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02255-y · Cited by 45
Peng, S., Lin, W., Li, Z., Zhuang, R., Peng, S., Li, B., Chen, B., Luo, Y., Ou, Y., Zhuang, W., et al. (2026) · Advanced Science · doi:10.1002/advs.202508588 · Cited by 7
Metadata
- Authors
- Xu, R., Vujić, N., Bianco, V., Reinisch, I., Kratky, D., Krstic, J., & Prokesch, A.
- Venue
- Trends in Endocrinology & Metabolism
- Publisher
- Elsevier BV
- Published
- 2024-11
- Volume
- 35
- Issue
- 11
- Pages
- 981-995
- ISSN
- 1043-2760 (ISSN-L)
- OpenAlex
- W4396646543
- Cited by
- 95
- References
- 51
- FWCI
- 10.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- BioTechMed-Graz
- Austrian Science Fund (SFB 10.55776/F73, DK-MCD 10.55776/W1226)
- Medizinische Universitat Graz
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lipid-associated macrophages between aggravation and alleviation of metabolic diseases. https://app.cochat.ai/papers/10.1016/j.tem.2024.04.009
- The paper
- Xu, R., Vujić, N., Bianco, V., Reinisch, I., Kratky, D., Krstic, J., & Prokesch, A. (2024). Lipid-associated macrophages between aggravation and alleviation of metabolic diseases. Trends in Endocrinology & Metabolism. https://doi.org/10.1016/j.tem.2024.04.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.